Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.770
-0.030 (-1.67%)
At close: Feb 21, 2025, 4:00 PM
1.800
+0.030 (1.69%)
After-hours: Feb 21, 2025, 5:01 PM EST
Rockwell Medical Revenue
Rockwell Medical had revenue of $28.32M in the quarter ending September 30, 2024, with 19.12% growth. This brings the company's revenue in the last twelve months to $98.92M, up 22.37% year-over-year. In the year 2023, Rockwell Medical had annual revenue of $83.61M with 14.84% growth.
Revenue (ttm)
$98.92M
Revenue Growth
+22.37%
P/S Ratio
0.54
Revenue / Employee
$417,371
Employees
237
Market Cap
57.20M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 83.61M | 10.80M | 14.84% |
Dec 31, 2022 | 72.81M | 10.88M | 17.57% |
Dec 31, 2021 | 61.93M | -266.00K | -0.43% |
Dec 31, 2020 | 62.20M | 894.00K | 1.46% |
Dec 31, 2019 | 61.30M | -2.09M | -3.29% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
RMTI News
- 2 days ago - Rockwell Medical to Release Fourth Quarter and Full-Year 2024 Results on Thursday, March 20, 2025 - Business Wire
- 18 days ago - Rockwell Medical Adds Single-Use Bicarbonate Cartridge to Hemodialysis Concentrates Product Portfolio - Business Wire
- 2 months ago - Rockwell Medical Enters into a Multi-Year Product Purchase Agreement with the World's Leading Provider of Dialysis Products and Services - Business Wire
- 2 months ago - UPDATE: Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card - GlobeNewsWire
- 2 months ago - Kellner Group Urges Stockholders of AIM Immunotech to Vote Gold Card - GlobeNewsWire
- 2 months ago - Rockwell Medical Promotes Jesse Neri to Chief Financial Officer - Business Wire
- 2 months ago - Rockwell Medical Partners with HydroCare to Distribute and Install its Dry Acid Concentrate Mix System - Business Wire
- 3 months ago - Rockwell Medical Expands Distribution in the Philippines - Business Wire